John Mondick

804 total citations
32 papers, 598 citations indexed

About

John Mondick is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Mondick has authored 32 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Mondick's work include Pharmaceutical studies and practices (6 papers), Statistical Methods in Clinical Trials (4 papers) and Child Nutrition and Feeding Issues (3 papers). John Mondick is often cited by papers focused on Pharmaceutical studies and practices (6 papers), Statistical Methods in Clinical Trials (4 papers) and Child Nutrition and Feeding Issues (3 papers). John Mondick collaborates with scholars based in United States, Germany and Japan. John Mondick's co-authors include Jeffrey S. Barrett, Gabriel J. Robbie, Liang Zhao, Lorin Roskos, Genevieve A. Losonsky, Mahesh Narayan, Athena F. Zuppa, Joan I. Schall, Maria R. Mascarenhas and Mark L. Bernstein and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Anesthesia & Analgesia.

In The Last Decade

John Mondick

29 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Mondick United States	15	139	116	101	100	93	32	598
Søren Blirup-Jensen Sweden	13	134 1.0×	115 1.0×	110 1.1×	113 1.1×	87 0.9×	16	974
Sonia L. La’ulu United States	16	87 0.6×	66 0.6×	141 1.4×	129 1.3×	67 0.7×	44	800
Yaping Zhang China	15	158 1.1×	63 0.5×	142 1.4×	180 1.8×	93 1.0×	56	1.2k
Samir Mallat Lebanon	18	66 0.5×	65 0.6×	131 1.3×	151 1.5×	154 1.7×	41	911
Thomas Jouvé France	17	97 0.7×	69 0.6×	68 0.7×	135 1.4×	233 2.5×	82	829
Tai‐Tsung Chang Taiwan	15	108 0.8×	143 1.2×	151 1.5×	91 0.9×	84 0.9×	31	657
Борис Зингерман Israel	16	180 1.3×	112 1.0×	153 1.5×	97 1.0×	207 2.2×	53	1.1k
Dae‐Hyun Ko South Korea	15	44 0.3×	81 0.7×	125 1.2×	97 1.0×	82 0.9×	118	756
Murtadha Al‐Khabori Oman	16	57 0.4×	98 0.8×	133 1.3×	136 1.4×	128 1.4×	103	960
Verena Gotta Switzerland	14	87 0.6×	83 0.7×	84 0.8×	82 0.8×	40 0.4×	56	548

Countries citing papers authored by John Mondick

Since Specialization

Citations

This map shows the geographic impact of John Mondick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Mondick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Mondick more than expected).

Fields of papers citing papers by John Mondick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Mondick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Mondick. The network helps show where John Mondick may publish in the future.

Co-authorship network of co-authors of John Mondick

This figure shows the co-authorship network connecting the top 25 collaborators of John Mondick. A scholar is included among the top collaborators of John Mondick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Mondick. John Mondick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mondick, John, et al.. (2025). Bayesian Population Pharmacokinetic Modeling of Ondansetron for Neonatal Opioid Withdrawal Syndrome. Clinical and Translational Science. 18(2). e70147–e70147.

Byrne, Barry J., Giancarlo Parenti, Benedikt Schoser, et al.. (2024). Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease. Frontiers in Neurology. 15. 1451512–1451512. 6 indexed citations

Tachibana, Masaya, et al.. (2024). Population pharmacokinetics of total and unbound valemetostat and platelet dynamics in healthy volunteers and patients with non‐Hodgkin lymphoma. CPT Pharmacometrics & Systems Pharmacology. 13(10). 1641–1654. 6 indexed citations

Mondick, John, et al.. (2023). Bayesian estimation in NONMEM. CPT Pharmacometrics & Systems Pharmacology. 13(2). 192–207. 7 indexed citations

Mondick, John, et al.. (2020). Latent process model of the 6-minute walk test in Duchenne muscular dystrophy. Journal of Pharmacokinetics and Pharmacodynamics. 47(1). 91–104. 6 indexed citations

Mondick, John, et al.. (2020). Population pharmacokinetics of adalimumab biosimilar adalimumab‐adbm and reference product in healthy subjects and patients with rheumatoid arthritis to assess pharmacokinetic similarity. British Journal of Clinical Pharmacology. 86(11). 2274–2285. 20 indexed citations

Rovner, Alisha J., Joan I. Schall, John Mondick, Hongming Zhuang, & Maria R. Mascarenhas. (2013). Delayed Small Bowel Transit in Children With Cystic Fibrosis and Pancreatic Insufficiency. Journal of Pediatric Gastroenterology and Nutrition. 57(1). 81–84. 23 indexed citations

Robbie, Gabriel J., Liang Zhao, John Mondick, Genevieve A. Losonsky, & Lorin Roskos. (2012). Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children. Antimicrobial Agents and Chemotherapy. 56(9). 4927–4936. 114 indexed citations

Mondick, John, et al.. (2012). Plasma topiramate concentrations resulting from doses associated with neuroprotection against white matter injury and stroke in two strains of rat pups. Pediatric Research. 73(3). 317–324. 3 indexed citations

10.

Mondick, John, Brendan M. Johnson, Mark Sale, et al.. (2009). Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months. European Journal of Clinical Pharmacology. 66(1). 77–86. 14 indexed citations

11.

Zuppa, Athena F., John Mondick, Lisa E. Davis, & David Cohen. (2009). Population Pharmacokinetics of Ketorolac in Neonates and Young Infants. American Journal of Therapeutics. 16(2). 143–146. 21 indexed citations

12.

Thompson, Patrick A., Manish Gupta, Gary L. Rosner, et al.. (2008). Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group. Cancer Chemotherapy and Pharmacology. 62(6). 1027–1037. 21 indexed citations

13.

Barrett, Jeffrey S., et al.. (2008). Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy. BMC Medical Informatics and Decision Making. 8(1). 6–6. 54 indexed citations

14.

Mondick, John, Bhuvana Jayaraman, Patrick A. Thompson, et al.. (2008). Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults. Cancer Chemotherapy and Pharmacology. 63(2). 229–238. 63 indexed citations

15.

Zuppa, Athena F., Bhuvana Jayaraman, Dimple Patel, et al.. (2007). An Informatics Approach to Assess Pediatric Pharmacotherapy: Design and Implementation of a Hospital Drug Utilization System. The Journal of Clinical Pharmacology. 47(9). 1172–1180. 8 indexed citations

16.

Zuppa, Athena F., Susan C. Nicolson, Peter C. Adamson, et al.. (2006). Population Pharmacokinetics of Milrinone in Neonates with Hypoplastic Left Heart Syndrome Undergoing Stage I Reconstruction. Anesthesia & Analgesia. 102(4). 1062–1069. 38 indexed citations

17.

Zuppa, Athena F., Peter C. Adamson, John Mondick, et al.. (2005). Drug Utilization in the Pediatric Intensive Care Unit: Monitoring Prescribing Trends and Establishing Prioritization of Pharmacotherapeutic Evaluation of Critically Ill Children. The Journal of Clinical Pharmacology. 45(11). 1305–1312. 25 indexed citations

18.

Garimella, Τushar, D D Ross, Julie L. Eiseman, et al.. (2004). Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors. Cancer Chemotherapy and Pharmacology. 55(2). 101–109. 14 indexed citations

19.

Pieniaszek, Henry J., Sherwin K. B. Sy, William F. Ebling, et al.. (2002). Safety, Tolerability, Pharmacokinetics, and Time Course of Pharmacologic Response of the Active Metabolite of Roxifiban, XV459, a Glycoprotein IIb/IIIa Antagonist, following Oral Administration in Healthy Volunteers. The Journal of Clinical Pharmacology. 42(7). 738–753. 13 indexed citations

20.

Fossler, Michael J., William F. Ebling, David M. Kornhauser, et al.. (2002). Integrated Pharmacokinetic/Pharmacodynamic Model of XV459, a Potent and Specific GPIIb/IIIa Inhibitor, in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 42(12). 1326–1334. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact